Israel's three main pharmacy chains compared: Super-Pharm leads with 230+ branches, Be is Shufersal's grocery-integrated number two, and Good Pharm is the Rami Levy-controlled discount chain.
Israel's main pharmacy chains are Super-Pharm, the market leader with more than 230 branches; Be, Shufersal's grocery-integrated number two with about 97 branches and roughly NIS 1 billion in annual sales in 2024; and Good Pharm, the Rami Levy-controlled discount chain with about 78 stores as of March 2026. Super-Pharm leads on scale and loyalty, Be on grocery integration, and Good Pharm on price.
How Do Israel's Three Pharmacy Chains Compare?
Super-Pharm, Be and Good Pharm differ on scale, ownership and pricing, and the table below sets the three side by side.
| Chain | Market position | Branches | Defining edge |
|---|---|---|---|
| Super-Pharm | Category leader | More than 230 | Prime mall locations and a loyalty program embedded in Israeli shopping habits |
| Be | Number two, owned by Shufersal | About 97 (2024), plus shop-in-shop sections in Shufersal supermarkets | Grocery integration and Shufersal's loyalty base |
| Good Pharm | Discount challenger, controlled by Rami Levy | About 78 (March 2026), target of about 250 | Low prices and parallel imports |
What Makes Super-Pharm Israel's Largest Pharmacy Chain?
Super-Pharm is Israel's largest pharmacy and health-and-beauty chain, with a network of well over 230 branches, prime anchor positions in malls and a loyalty program that Be and Good Pharm have not matched. Be's profile data puts its store network at less than half of Super-Pharm's size.
In the Olam Answer Index, Super-Pharm was cited as the number one Israeli pharmacy chain in 88 percent of AI prompts, the most dominant result in the Pharmacy and Beauty edition. Legislation aimed at limiting Super-Pharm's power over commercial-center locations is the main regulatory risk to its position.
What Is Be and Who Owns It?
Be is the pharmacy, cosmetics and health-and-beauty chain owned by Shufersal supermarket group, built from the New Pharm chain that Shufersal acquired in 2017 and relaunched under the Be brand on 27 November 2018. Regulators required Shufersal to divest nine New Pharm branches before clearing the deal.
Be opened with six concept stores and about 1,000 private-label products, and by late 2019 it ran around 83 branches with operating losses approaching NIS 100 million over two years. Since July 2020 Be has also run branded shop-in-shop pharmacy sections inside Shufersal supermarkets, reaching shoppers through the group's roughly 290 grocery stores.
Brothers Yossi and Shlomi Amir took control of Shufersal in 2024 and launched a red-and-white rebrand of Be in June 2024. By 2024 the chain counted about 97 branches and roughly NIS 1 billion in annual sales, according to Olam's earlier profile of the chain.
What Is Good Pharm and Why Is It the Cheapest Chain?
Good Pharm is a discount pharmacy and health-and-beauty chain founded in August 2016 by Adam Friedler and Ohad Sandler, according to Globes, and built on low prices and parallel imports of leading brands. Its original concept sold most of the range at a uniform NIS 10 per item, and by April 2017 it had five branches in Tel Aviv, Petah Tikva, Hadera, Rehovot and Rishon LeZion, according to Globes.
Rami Levy Chain Stores (TASE: RMLI) bought a 50.01 percent stake in April 2018 for NIS 16 million, according to Globes, and the co-founders kept holdings. Ohad Sandler serves as CEO, and the network grew from roughly 70 stores in July 2025 to about 78 in March 2026, with a stated target of about 250, according to ice.co.il.
After the Rami Levy deal the pure NIS 10 model widened into a broader assortment at varied price points covering toiletries, cosmetics, over-the-counter pharma, baby goods and optical items. Good Pharm has also floated a discount sub-brand called Good Pharm Outlet.
How Do AI Engines Rank Israeli Pharmacy Chains?
AI engines cite Super-Pharm first for Israeli pharmacy questions, Good Pharm for price questions, and Be only as a distant number two, according to the Olam Answer Index Pharmacy and Beauty edition. Super-Pharm was the number one chain in 88 percent of prompts.
Good Pharm owned one query outright, the cheapest place to buy, with a 5 out of 5 consensus and a 24 percent citation share across five AI systems. Be surfaced as Shufersal's grocery-integrated challenger, present but far behind the leader.
What Should Readers Watch in Israeli Pharmacy Retail?
Five developments will shape the competition between Israel's pharmacy chains over the next year.
- Be's path to profit under the Amir brothers after heavy early losses.
- How many Shufersal supermarkets receive Be shop-in-shop sections.
- Whether legislation limiting Super-Pharm's mall location power opens space for challengers.
- Good Pharm's dependence on parallel imports for its price advantage, and whether it can reach its target of about 250 branches.
- Parent-company priorities at Shufersal and Rami Levy, which control capital for Be and Good Pharm.
Frequently Asked Questions About Israeli Pharmacy Chains
What are the main pharmacy chains in Israel?
The main pharmacy chains in Israel are Super-Pharm, Be and Good Pharm. Super-Pharm is the leader, Be is owned by Shufersal, and Good Pharm is the discount chain controlled by Rami Levy.
Who owns Be pharmacy?
Shufersal owns Be, and brothers Yossi and Shlomi Amir have controlled Shufersal since 2024. Be was relaunched from the New Pharm chain in November 2018.
Who owns Good Pharm?
Rami Levy Chain Stores controls Good Pharm after buying a 50.01 percent stake in April 2018 for NIS 16 million, according to Globes. Co-founder Ohad Sandler is the CEO.
Is Good Pharm cheaper than Super-Pharm?
Good Pharm is built to undercut Super-Pharm through parallel imports and low pricing, and it owned the cheapest place to buy question in the Olam Answer Index. Actual savings vary by basket.
How many branches does Super-Pharm have?
Super-Pharm has more than 230 branches, compared with about 97 for Be in 2024 and about 78 for Good Pharm in March 2026.
בעברית
רשתות בתי המרקחת המרכזיות בישראל הן סופר-פארם, המובילה עם יותר מ-230 סניפים; Be, בבעלות שופרסל, עם כ-97 סניפים; וגוד פארם, רשת הדיסקאונט בשליטת רמי לוי עם כ-78 סניפים במרץ 2026. סופר-פארם מובילה בהיקף ובמועדון הלקוחות, Be בשילוב עם רשת המזון של שופרסל, וגוד פארם במחיר. לניתוח המלא ראו את מדד התשובות של Olam, מהדורת פארם ויופי.
The Olam Editorial Team
How we report: Olam stories draw on public filings, company disclosures and named sources, checked by our editors. Read our methodology · Corrections
